Article Details
Retrieved on: 2019-01-05 19:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Sofinnova Ventures</b> Inc purchased a new position in shares of Entasis Therapeutics during the 3rd quarter worth approximately $12,840,000. Finally ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here